DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Salem R, Gabr A, Riaz A. et al.
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.
Hepatology 2018;
68 (04) 1429-1440
We do not assume any responsibility for the contents of the web pages of other providers.